6 Followers on Owler

Fennec

is a North Carolina-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of pediatric cancer... Read more
OverviewCompetitorsFundingNews & Insights

Fennec

is a North Carolina-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of pediatric cancer... Read more
Fennec CEO: Jeffrey S. Hackman

CEO

Jeffrey S. Hackman

CEO Approval Rating

90/100

1996

PublicNASDAQFENC

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
$51M
Employees
10
Funding
$140.4M

News

Funding
Nov 18, 2025
GlobeNewswire
Fennec received $40.3M in Post-IPO Equity Funding

Fennec Competitors

1Y-mAbs
2Day One Biopharmaceuticals
3Oncoheroes Biosciences
Unlock more competitors

Trending Companies